The impact of SARS-CoV-2 immunization on COVID-19 disease course in people with myasthenia gravis.
Christos BakirtzisMarina-Kleopatra BozikiMaria-Valeria KarakasiTheodoros MoysiadisNikolaos GrigoriadisPublished in: Muscle & nerve (2023)
Sars-Cov-2 vaccination significantly reduces hospitalization and mortality due to COVID-19 in people with myasthenia gravis. This study regarding the efficacy of these vaccines, together with previous studies regarding their safety, provide evidence to support their use in people with myasthenia gravis. This article is protected by copyright. All rights reserved.